Trial Profile
A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. in the Treatment of Subjects With Symptomatic Seasonal Allergic Rhinitis (SAR)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary) ; Fexofenadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Organon; Schering-Plough
- 23 Nov 2008 New trial record.